28 results
424B4
PCSA
Processa Pharmaceuticals Inc
29 Jan 24
Prospectus supplement with pricing info
4:15pm
31, 2024; (ii) a bonus of $50,000 upon the achievement of each of the following two milestones: (1) upon the closing stock price above $1.00 per
8-K
z3wdhm9j5see17s6g
8 Aug 23
Processa Pharmaceuticals Appoints Life Sciences Industry Veteran George Ng as Chief Executive Officer
10:30am
8-K
EX-1.1
r51im7
20 Aug 21
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-1.1
syq4ons
6 Oct 20
Processa Pharmaceuticals Announces Pricing of $19.2 Million Public Offering and Uplisting to the Nasdaq Capital Market
4:05pm
424B4
e61lcpspgj2nobneo
5 Oct 20
Prospectus supplement with pricing info
4:16pm
DEF 14A
m5io01
26 Apr 19
Definitive proxy
5:02pm